Skip to main content
SpringerLink
Log in

New Innovations and Treatments for Chronic Rhinosinusitis

  • Chapter
  • First Online:
Contemporary Rhinology: Science and Practice

  • 273 Accesses

Abstract

This chapter describes the new innovations and treatments in rhinosinusitis. (Fokkens et al., Rhinology 58: 1–464, 2020).

Firstly, there is a new classification for chronic rhinosinusitis. Secondly, there has been rapid progress in the new innovations used to treat chronic rhinosinusitis. This new classification has significant impact on treatment choices and will be used in this chapter. New innovations and treatments directed to various forms of CRS are discussed. The new innovations include balloon technology dilatation, drug-eluting stents and biologicals in particular.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1–464.

    Google Scholar 

  2. Levy JM, Marino MJ, McCoul ED. Paranasal sinus balloon catheter dilation for treatment of chronic rhinosinusitis: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2016;154(1):33–40.

    Article  PubMed  Google Scholar 

  3. Jenks M, Willits I, Turner EE, Hewitt N, Arber M, Cole H, et al. The XprESS multi-sinus dilation system for the treatment of chronic sinusitis: a NICE medical technology guidance. Appl Health Econ Health Policy. 2017;15(5):567–82.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sinha P, Tharakan T, Payne S, Piccirillo JF. Balloon sinus dilation versus functional endoscopic sinus surgery for chronic rhinosinusitis: systematic review and meta-analysis. Ann Otol Rhinol Laryngol. 2023;132(5):578–88.

    Article  PubMed  Google Scholar 

  5. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1–464.

    PubMed  Google Scholar 

  6. Luong AU, Chua A, Alim BM, Olsson P, Javer A. Allergic fungal rhinosinusitis: the role and expectations of biologics. J Allergy Clin Immunol Pract. 2022;10(12):3156–62.

    Article  CAS  PubMed  Google Scholar 

  7. Weissman JD, Fernandez F, Hwang PH. Xylitol nasal irrigation in the management of chronic rhinosinusitis: a pilot study. Laryngoscope. 2011;121:2468–72.

    Article  PubMed  Google Scholar 

  8. Lin L, Tang X, Wei J, Dai F, Sun G. Xylitol nasal irrigation in the treatment of chronic rhinosinusitis. Am J Otolaryngol. 2017;38:383–9.

    Article  PubMed  Google Scholar 

  9. Rabago D, Kille T, Mundt M, Obasi C. Results of a RCT assessing saline and xylitol nasal irrigation for CRS and fatigue in gulf war illness. Laryngoscope Investig Otolaryngol. 2020;5(4):613–20.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kim DH, Kim Y, Lim IG, Cho JH, Park YJ, Kim SW, et al. Effect of postoperative xylitol nasal irrigation on patients with Sinonasal diseases. Otolaryngol Head Neck Surg. 2019;160(3):550–5.

    Article  PubMed  Google Scholar 

  11. Hox V, Lourijsen E, Jordens A, Aasbjerg K, Agache I, Alobid I, et al. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy. 2020;10:1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, et al. Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)-a EAACI position paper. Allergy. 2019;74(1):28–39.

    Article  PubMed  Google Scholar 

  13. Oykhman P, Paramo FA, Bousquet J, Kennedy DW, Brignardello-Petersen R, Chu DK. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis. J Allergy Clin Immunol. 2022;149(4):1286–95.

    Article  CAS  PubMed  Google Scholar 

  14. Senior BA, Schlosser RJ, Bosso J, Soler ZM. Efficacy of the exhalation delivery system with fluticasone in patients who remain symptomatic on standard nasal steroid sprays. Int Forum Allergy Rhinol. 2021;11(5):837–45.

    Article  PubMed  Google Scholar 

  15. Hwang SH, Kim SW, Basurrah MA, Kim DH. Efficacy of steroid-impregnated spacers after endoscopic sinus surgery in chronic rhinosinusitis: a systematic review and meta-analysis. Clin Exp Otorhinolaryngol. 2023;16(2):148–58.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Taulu R, Bizaki AJ, Numminen J, Rautiainen M. A prospective, randomized clinical study comparing drug eluting stent therapy and intranasal corticoid steroid therapy in the treatment of patients with chronic rhinosinusitis. Rhinology. 2017;55(3):218–26.

    Article  CAS  PubMed  Google Scholar 

  17. Taulu R, Sillanpää N, Numminen J, Rautiainen M. Ethmoidal drug-eluting stent therapy is not superior to nasal corticosteroid spray in the prevention of endoscopic sinus surgery: results from a randomised, clinical trial. Clin Otolaryngol. 2020;45(3):402–8.

    Article  PubMed  Google Scholar 

  18. Huang Z, Zhou B, Wang D, Zang H, Zhang H, Wang H, et al. Comparison of bioabsorbable steroid-eluting sinus stents versus Nasopore after endoscopic sinus surgery: a multicenter, randomized, controlled, single-blinded clinical trial. Ear Nose Throat J. 2022;101(4):260–7.

    Article  PubMed  Google Scholar 

  19. Fokkens W, Van Der Lans R, Reitsma S. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis. Expert Opin Biol Ther. 2021;21(5):575–85.

    Article  CAS  PubMed  Google Scholar 

  20. Agache I, Song Y, Alonso-Coello P, Vogel Y, Rocha C, Solà I, et al. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines. Allergy. 2021;76(8):2337–53.

    Article  CAS  PubMed  Google Scholar 

  21. Bachert C, Han JK, Desrosiers MY, Gevaert P, Heffler E, Hopkins C, et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2022;149(4):1309–17.e12.

    Article  CAS  PubMed  Google Scholar 

  22. Fokkens WJ, Viskens AS, Backer V, Conti D, De Corso E, Gevaert P, et al. EPOS/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinology. 2023;61(3):194–202.

    CAS  PubMed  Google Scholar 

  23. Rampi A, Vinciguerra A, Tanzini U, Bussi M, Trimarchi M. Comparison of guidelines for prescription and follow-up of biologics for chronic rhinosinusitis with nasal polyps. Eur Arch Otorhinolaryngol. 2023;280(1):39–46.

    Article  PubMed  Google Scholar 

  24. van der Lans RJL, Fokkens WJ, Adriaensen G, Hoven DR, Drubbel JJ, Reitsma S. Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps. Allergy. 2022;77(2):670–4.

    Article  PubMed  Google Scholar 

  25. De Corso E, Pasquini E, Trimarchi M, La Mantia I, Pagella F, Ottaviano G, et al. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational phase IV real-life study (DUPIREAL). Allergy. 2023; https://doi.org/10.1111/all.15772.

  26. van der Lans RJL, Otten JJ, Adriaensen G, Hoven DR, Benoit LB, Fokkens WJ, et al. Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months. Allergy. 2023; https://doi.org/10.1111/all.15796.

  27. Gramegna A, Contarini M, Aliberti S, Casciaro R, Blasi F, Castellani C. From Ivacaftor to triple combination: a systematic review of efficacy and safety of CFTR modulators in people with cystic fibrosis. Int J Mol Sci. 2020;21(16):5882.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Yousif Hamdan AH, Zakaria F, Lourdes Pormento MK, Lawal OS, Opiegbe A, Zahid S, et al. Cystic fibrosis transmembrane conductance regulator protein modulators in children and adolescents with different CF genotypes - systematic review and meta-analysis. Curr Rev Clin Exp Pharmacol. 2023; https://doi.org/10.2174/2772432818666230201094115.

  29. Jaques R, Shakeel A, Hoyle C. Novel therapeutic approaches for the management of cystic fibrosis. Multidiscip Respir Med. 2020;15(1):690.

    PubMed  PubMed Central  Google Scholar 

  30. Arzoun H, Srinivasan M, Thangaraj SR, Thomas SS, Yarema A, Lee B, et al. Recent advancements in the management of anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic review. Cureus. 2022;14(2):e21814.

    PubMed  PubMed Central  Google Scholar 

  31. Springer JM, Kalot MA, Husainat NM, Byram KW, Dua AB, James KE, et al. Granulomatosis with polyangiitis and microscopic polyangiitis: a systematic review and meta-analysis of benefits and harms of common treatments. ACR Open Rheumatol. 2021;3(3):196–205.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Steinfeld J, Bradford ES, Brown J, Mallett S, Yancey SW, Akuthota P, et al. Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis. J Allergy Clin Immunol. 2019;143(6):2170–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands

    Wytske J. Fokkens & Sietze Reitsma

Authors
  1. Wytske J. Fokkens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sietze Reitsma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wytske J. Fokkens .

Editor information

Editors and Affiliations

  1. Liverpool Head and Neck Centre, Liverpool University Hospitals, Foundation Trust, Liverpool, UK

    Andrew C. Swift

  2. Otolaryngology, Freeman Hospital, Newcastle upon Tyne, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

    Sean Carrie

  3. Department of Otolaryngology, Tata Memorial Hospital, Mumbai, Maharashtra, India

    Christopher de Souza

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fokkens, W.J., Reitsma, S. (2023). New Innovations and Treatments for Chronic Rhinosinusitis. In: Swift, A.C., Carrie, S., de Souza, C. (eds) Contemporary Rhinology: Science and Practice. Springer, Cham. https://doi.org/10.1007/978-3-031-28690-2_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-28690-2_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-28689-6

  • Online ISBN: 978-3-031-28690-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation